Top

Published in:

01-06-2012 | NON-THEMATIC REVIEW

Discoidin domain receptor tyrosine kinases: new players in cancer progression

Authors: Rajeshwari R. Valiathan, Marta Marco, Birgit Leitinger, Celina G. Kleer, Rafael Fridman

Published in: Cancer and Metastasis Reviews | Issue 1-2/2012

Abstract

Almost all human cancers display dysregulated expression and/or function of one or more receptor tyrosine kinases (RTKs). The strong causative association between altered RTK function and cancer progression has been translated into novel therapeutic strategies that target these cell surface receptors in cancer. Yet, the full spectrum of RTKs that may alter the oncogenic process is not completely understood. Accumulating evidence suggests that a unique set of RTKs known as the discoidin domain receptors (DDRs) play a key role in cancer progression by regulating the interactions of tumor cells with their surrounding collagen matrix. The DDRs are the only RTKs that specifically bind to and are activated by collagen. DDRs control cell and tissue homeostasis by acting as collagen sensors, transducing signals that regulate cell polarity, tissue morphogenesis, and cell differentiation. In cancer, DDRs are hijacked by tumor cells to disrupt normal cell–matrix communication and initiate pro-migratory and pro-invasive programs. Importantly, several cancer types exhibit DDR mutations, which are thought to alter receptor function and contribute to cancer progression. Other evidence suggests that the actions of DDRs in cancer are complex, either promoting or suppressing tumor cell behavior in a DDR type/isoform specific- and context-dependent manner. Thus, there is still a considerable gap in our knowledge of DDR actions in cancer tissues. This review summarizes and discusses the current knowledge on DDR expression and function in cancer. It is hoped that this effort will encourage more research into these poorly understood but unique RTKs, which have the potential of becoming novel therapeutic targets in cancer.

Johnson, J. D., Edman, J. C., & Rutter, W. J. (1993). A receptor tyrosine kinase found in breast carcinoma cells has an extracellular discoidin I-like domain. Proceedings of the National Academy of Sciences of the United States of America, 90(22), 10891.PubMedCrossRef

Di Marco, E., Cutuli, N., Guerra, L., Cancedda, R., & De Luca, M. (1993). Molecular cloning of trkE, a novel trk-related putative tyrosine kinase receptor isolated from normal human keratinocytes and widely expressed by normal human tissues. The Journal of Biological Chemistry, 268(32), 24290–24295.PubMed

Zerlin, M., Julius, M. A., & Goldfarb, M. (1993). NEP: A novel receptor-like tyrosine kinase expressed in proliferating neuroepithelia. Oncogene, 8(10), 2731–2739.PubMed

Karn, T., Holtrich, U., Brauninger, A., Bohme, B., Wolf, G., Rubsamen-Waigmann, H., et al. (1993). Structure, expression and chromosomal mapping of TKT from man and mouse: A new subclass of receptor tyrosine kinases with a factor VIII-like domain. Oncogene, 8(12), 3433–3440.PubMed

Perez, J. L., Shen, X., Finkernagel, S., Sciorra, L., Jenkins, N. A., Gilbert, D. J., et al. (1994). Identification and chromosomal mapping of a receptor tyrosine kinase with a putative phospholipid binding sequence in its ectodomain. Oncogene, 9(1), 211–219.PubMed

Perez, J. L., Jing, S. Q., & Wong, T. W. (1996). Identification of two isoforms of the Cak receptor kinase that are coexpressed in breast tumor cell lines. Oncogene, 12(7), 1469–1477.PubMed

Lai, C., & Lemke, G. (1994). Structure and expression of the Tyro 10 receptor tyrosine kinase. Oncogene, 9(3), 877–883.PubMed

Laval, S., Butler, R., Shelling, A. N., Hanby, A. M., Poulsom, R., & Ganesan, T. S. (1994). Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line. Cell Growth & Differentiation, 5(11), 1173–1183.

Sanchez, M. P., Tapley, P., Saini, S. S., He, B., Pulido, D., & Barbacid, M. (1994). Multiple tyrosine protein kinases in rat hippocampal neurons: Isolation of Ptk-3, a receptor expressed in proliferative zones of the developing brain. Proceedings of the National Academy of Sciences of the United States of America, 91(5), 1819–1823.PubMedCrossRef

10.

Alves, F., Vogel, W., Mossie, K., Millauer, B., Hofler, H., & Ullrich, A. (1995). Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene, 10(3), 609–618.PubMed

11.

Vogel, W., Gish, G. D., Alves, F., & Pawson, T. (1997). The discoidin domain receptor tyrosine kinases are activated by collagen. Molecular Cell, 1(1), 13–23.PubMedCrossRef

12.

Shrivastava, A., Radziejewski, C., Campbell, E., Kovac, L., McGlynn, M., Ryan, T. E., et al. (1997). An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. Molecular Cell, 1(1), 25–34.PubMedCrossRef

13.

Lemmon, M. A., & Schlessinger, J. (2010). Cell signaling by receptor tyrosine kinases. Cell, 141(7), 1117–1134. doi:10.1016/j.cell.2010.06.011.PubMedCrossRef

14.

Kiedzierska, A., Smietana, K., Czepczynska, H., & Otlewski, J. (2007). Structural similarities and functional diversity of eukaryotic discoidin-like domains. Biochimica et Biophysica Acta, 1774(9), 1069–1078.PubMed

15.

Alexander, S., Sydow, L. M., Wessels, D., & Soll, D. R. (1992). Discoidin proteins of Dictyostelium are necessary for normal cytoskeletal organization and cellular morphology during aggregation. Differentiation, 51(3), 149–161.PubMedCrossRef

16.

Baumgartner, S., Hofmann, K., Chiquet-Ehrismann, R., & Bucher, P. (1998). The discoidin domain family revisited: New members from prokaryotes and a homology-based fold prediction. Protein Science, 7(7), 1626–1631.PubMedCrossRef

17.

Leitinger, B. (2011). Transmembrane collagen receptors. Annual Review of Cell and Developmental Biology, 27, 265–290. doi:10.1146/annurev-cellbio-092910-154013.PubMedCrossRef

18.

Playford, M. P., Butler, R. J., Wang, X. C., Katso, R. M., Cooke, I. E., & Ganesan, T. S. (1996). The genomic structure of discoidin receptor tyrosine kinase. Genome Research, 6(7), 620–627.PubMedCrossRef

19.

Alves, F., Saupe, S., Ledwon, M., Schaub, F., Hiddemann, W., & Vogel, W. F. (2001). Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: Differential expression in human colon cancer cell lines. The FASEB Journal, 15(7), 1321–1323.

20.

Curat, C. A., Eck, M., Dervillez, X., & Vogel, W. F. (2001). Mapping of epitopes in discoidin domain receptor 1 critical for collagen binding. The Journal of Biological Chemistry, 276(49), 45952–45958.PubMedCrossRef

21.

Agarwal, G., Kovac, L., Radziejewski, C., & Samuelsson, S. J. (2002). Binding of discoidin domain receptor 2 to collagen I: An atomic force microscopy investigation. Biochemistry, 41(37), 11091–11098.PubMedCrossRef

22.

Agarwal, G., Mihai, C., & Iscru, D. F. (2007). Interaction of discoidin domain receptor 1 with collagen type 1. Journal of Molecular Biology, 367(2), 443–455.PubMedCrossRef

23.

Leitinger, B. (2003). Molecular analysis of collagen binding by the human discoidin domain receptors, DDR1 and DDR2. Identification of collagen binding sites in DDR2. The Journal of Biological Chemistry, 278(19), 16761–16769.PubMedCrossRef

24.

Noordeen, N. A., Carafoli, F., Hohenester, E., Horton, M. A., & Leitinger, B. (2006). A transmembrane leucine zipper is required for activation of the dimeric receptor tyrosine kinase DDR1. The Journal of Biological Chemistry, 281(32), 22744–22751.PubMedCrossRef

25.

Mihai, C., Chotani, M., Elton, T. S., & Agarwal, G. (2009). Mapping of DDR1 distribution and oligomerization on the cell surface by FRET microscopy. Journal of Molecular Biology, 385(2), 432–445. doi:10.1016/j.jmb.2008.10.067.PubMedCrossRef

26.

Abdulhussein, R., Koo, D. H., & Vogel, W. F. (2008). Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1. The Journal of Biological Chemistry, 283(18), 12026–12033. doi:10.1074/jbc.M704592200.PubMedCrossRef

27.

Konitsiotis, A. D., Raynal, N., Bihan, D., Hohenester, E., Farndale, R. W., & Leitinger, B. (2008). Characterization of high affinity binding motifs for the discoidin domain receptor DDR2 in collagen. The Journal of Biological Chemistry, 283(11), 6861–6868.PubMedCrossRef

28.

Leitinger, B., Steplewski, A., & Fertala, A. (2004). The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2. Journal of Molecular Biology, 344(4), 993–1003.PubMedCrossRef

29.

Leitinger, B., & Kwan, A. P. (2006). The discoidin domain receptor DDR2 is a receptor for type X collagen. Matrix Biology, 25(6), 355–364.PubMedCrossRef

30.

Hou, G., Vogel, W., & Bendeck, M. P. (2001). The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair. The Journal of Clinical Investigation, 107(6), 727–735.PubMedCrossRef

31.

Farndale, R. W., Lisman, T., Bihan, D., Hamaia, S., Smerling, C. S., Pugh, N., et al. (2008). Cell-collagen interactions: The use of peptide Toolkits to investigate collagen-receptor interactions. Biochemical Society Transactions, 36(Pt 2), 241–250.PubMedCrossRef

32.

Xu, H., Raynal, N., Stathopoulos, S., Myllyharju, J., Farndale, R. W., & Leitinger, B. (2011). Collagen binding specificity of the discoidin domain receptors: Binding sites on collagens II and III and molecular determinants for collagen IV recognition by DDR1. Matrix Biology, 30(1), 16–26. doi:10.1016/j.matbio.2010.10.004.PubMedCrossRef

33.

Abdulhussein, R., McFadden, C., Fuentes-Prior, P., & Vogel, W. F. (2004). Exploring the collagen-binding site of the DDR1 tyrosine kinase receptor. The Journal of Biological Chemistry, 279(30), 31462–31470.PubMedCrossRef

34.

Ichikawa, O., Osawa, M., Nishida, N., Goshima, N., Nomura, N., & Shimada, I. (2007). Structural basis of the collagen-binding mode of discoidin domain receptor 2. EMBO Journal, 26(18), 4168–4176.PubMedCrossRef

35.

Carafoli, F., Bihan, D., Stathopoulos, S., Konitsiotis, A. D., Kvansakul, M., Farndale, R. W., et al. (2009). Crystallographic insight into collagen recognition by discoidin domain receptor 2. Structure, 17(12), 1573–1581. doi:10.1016/j.str.2009.10.012.PubMedCrossRef

36.

Lemeer, S., Bluwstein, A., Wu, Z., Leberfinger, J., Muller, K., Kramer, K., et al. (2011). Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1. Journal of Proteomics. doi:10.1016/j.jprot.2011.10.007.

37.

L’Hote, C. G., Thomas, P. H., & Ganesan, T. S. (2002). Functional analysis of discoidin domain receptor 1: Effect of adhesion on DDR1 phosphorylation. The FASEB Journal, 16(2), 234–236.

38.

Jonsson, M., & Andersson, T. (2001). Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells. Journal of Cell Science, 114(Pt 11), 2043–2053.PubMed

39.

Dejmek, J., Dib, K., Jonsson, M., & Andersson, T. (2003). Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion. International Journal of Cancer, 103(3), 344–351.CrossRef

40.

Roarty, K., & Serra, R. (2007). Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development, 134(21), 3929–3939.PubMedCrossRef

41.

Lu, K. K., Trcka, D., & Bendeck, M. P. (2011). Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src. Cardiovascular Pathology, 20(2), 71–76. doi:10.1016/j.carpath.2009.12.006.PubMedCrossRef

42.

Ikeda, K., Wang, L. H., Torres, R., Zhao, H., Olaso, E., Eng, F. J., et al. (2002). Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. The Journal of Biological Chemistry, 277(21), 19206–19212.PubMedCrossRef

43.

Yang, K., Kim, J. H., Kim, H. J., Park, I. S., Kim, I. Y., & Yang, B. S. (2005). Tyrosine 740 phosphorylation of discoidin domain receptor 2 by Src stimulates intramolecular autophosphorylation and Shc signaling complex formation. The Journal of Biological Chemistry, 280(47), 39058–39066.PubMedCrossRef

44.

Koo, D. H., McFadden, C., Huang, Y., Abdulhussein, R., Friese-Hamim, M., & Vogel, W. F. (2006). Pinpointing phosphotyrosine-dependent interactions downstream of the collagen receptor DDR1. FEBS Letters, 580(1), 15–22. doi:10.1016/j.febslet.2005.11.035.PubMedCrossRef

45.

Wang, C. Z., Su, H. W., Hsu, Y. C., Shen, M. R., & Tang, M. J. (2006). A discoidin domain receptor 1/SHP-2 signaling complex inhibits alpha2beta1-integrin-mediated signal transducers and activators of transcription 1/3 activation and cell migration. Molecular Biology of the Cell, 17(6), 2839–2852.PubMedCrossRef

46.

Yang, G., Li, Q., Ren, S., Lu, X., Fang, L., Zhou, W., et al. (2009). Proteomic, functional and motif-based analysis of C-terminal Src kinase-interacting proteins. Proteomics, 9(21), 4944–4961. doi:10.1002/pmic.200800762.PubMedCrossRef

47.

Huang, Y., Arora, P., McCulloch, C. A., & Vogel, W. F. (2009). The collagen receptor DDR1 regulates cell spreading and motility by associating with myosin IIA. Journal of Cell Science, 122(Pt 10), 1637–1646. doi:10.1242/jcs.046219.PubMedCrossRef

48.

Shintani, Y., Fukumoto, Y., Chaika, N., Svoboda, R., Wheelock, M. J., & Johnson, K. R. (2008). Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. The Journal of Cell Biology, 180(6), 1277–1289.PubMedCrossRef

49.

Hansen, C., Greengard, P., Nairn, A. C., Andersson, T., & Vogel, W. F. (2006). Phosphorylation of DARPP-32 regulates breast cancer cell migration downstream of the receptor tyrosine kinase DDR1. Experimental Cell Research, 312(20), 4011–4018. doi:10.1016/j.yexcr.2006.09.003.PubMedCrossRef

50.

Hilton, H. N., Stanford, P. M., Harris, J., Oakes, S. R., Kaplan, W., Daly, R. J., et al. (2008). KIBRA interacts with discoidin domain receptor 1 to modulate collagen-induced signalling. Biochimica et Biophysica Acta, 1783(3), 383–393.PubMedCrossRef

51.

Dejmek, J., Leandersson, K., Manjer, J., Bjartell, A., Emdin, S. O., Vogel, W. F., et al. (2005). Expression and signaling activity of Wnt-5a/discoidin domain receptor-1 and Syk plays distinct but decisive roles in breast cancer patient survival. Clinical Cancer Research, 11(2 Pt 1), 520–528.PubMed

52.

Kim, H. G., Hwang, S. Y., Aaronson, S. A., Mandinova, A., & Lee, S. W. (2011). DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. The Journal of Biological Chemistry, 286(20), 17672–17681. doi:10.1074/jbc.M111.236612.PubMedCrossRef

53.

Eswaramoorthy, R., Wang, C. K., Chen, W. C., Tang, M. J., Ho, M. L., Hwang, C. C., et al. (2010). DDR1 regulates the stabilization of cell surface E-cadherin and E-cadherin-mediated cell aggregation. Journal of Cellular Physiology, 224(2), 387–397. doi:10.1002/jcp.22134.PubMedCrossRef

54.

Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S. I., Williamson, P., Harrington, K., Leitinger, B., et al. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nature Cell Biology, 13(1), 49–58. doi:10.1038/ncb2133.PubMedCrossRef

55.

Olaso, E., Lin, H. C., Wang, L. H., & Friedman, S. L. (2011). Impaired dermal wound healing in discoidin domain receptor 2-deficient mice associated with defective extracellular matrix remodeling. Fibrogenesis & Tissue Repair, 4(1), 5. doi:10.1186/1755-1536-4-5.CrossRef

56.

Wang, C. Z., Hsu, Y. M., & Tang, M. J. (2005). Function of discoidin domain receptor I in HGF-induced branching tubulogenesis of MDCK cells in collagen gel. Journal of Cellular Physiology, 203(1), 295–304.PubMedCrossRef

57.

Wang, C. Z., Yeh, Y. C., & Tang, M. J. (2009). DDR1/E-cadherin complex regulates the activation of DDR1 and cell spreading. American Journal of Physiology. Cell Physiology, 297(2), C419–C429. doi:10.1152/ajpcell.00101.2009.PubMedCrossRef

58.

Yeh, Y. C., Wang, C. Z., & Tang, M. J. (2009). Discoidin domain receptor 1 activation suppresses alpha2beta1 integrin-dependent cell spreading through inhibition of Cdc42 activity. Journal of Cellular Physiology, 218(1), 146–156. doi:10.1002/jcp.21578.PubMedCrossRef

59.

Yeh, Y. C., Wu, C. C., Wang, Y. K., & Tang, M. J. (2011). DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Molecular Biology of the Cell, 22(7), 940–953. doi:10.1091/mbc.E10-08-0678.PubMedCrossRef

60.

Vonk, L. A., Doulabi, B. Z., Huang, C., Helder, M. N., Everts, V., & Bank, R. A. (2011). Collagen-induced expression of collagenase-3 by primary chondrocytes is mediated by integrin α1 and discoidin domain receptor 2: A protein kinase C-dependent pathway. Rheumatology, 50(3), 463–472. doi:10.1093/rheumatology/keq305.PubMedCrossRef

61.

Zhang, Y., Su, J., Yu, J., Bu, X., Ren, T., Liu, X., et al. (2011). An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of Runx2 activation. Journal of Bone and Mineral Research, 26(3), 604–617. doi:10.1002/jbmr.225.PubMedCrossRef

62.

Lin, K. L., Chou, C. H., Hsieh, S. C., Hwa, S. Y., Lee, M. T., & Wang, F. F. (2010). Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation. Journal of Bone and Mineral Research, 25(11), 2489–2503. doi:10.1002/jbmr.159.PubMedCrossRef

63.

Ongusaha, P. P., Kim, J. I., Fang, L., Wong, T. W., Yancopoulos, G. D., Aaronson, S. A., et al. (2003). p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO Journal, 22(6), 1289–1301.PubMedCrossRef

64.

Das, S., Ongusaha, P. P., Yang, Y. S., Park, J. M., Aaronson, S. A., & Lee, S. W. (2006). Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Research, 66(16), 8123–8130.PubMedCrossRef

65.

Vogel, W., Brakebusch, C., Fassler, R., Alves, F., Ruggiero, F., & Pawson, T. (2000). Discoidin domain receptor 1 is activated independently of beta(1) integrin. The Journal of Biological Chemistry, 275(8), 5779–5784.PubMedCrossRef

66.

Suh, H. N., & Han, H. J. (2011). Collagen I regulates the self-renewal of mouse embryonic stem cells through alpha2beta1 integrin- and DDR1-dependent Bmi-1. Journal of Cellular Physiology. doi:10.1002/jcp.22697.

67.

Chetoui, N., El Azreq, M. A., Boisvert, M., Bergeron, M. E., & Aoudjit, F. (2011). Discoidin domain receptor 1 expression in activated T cells is regulated by the ERK MAP kinase signaling pathway. Journal of Cellular Biochemistry, 112(12), 3666–3674. doi:10.1002/jcb.23300.PubMedCrossRef

68.

Ruiz, P. A., & Jarai, G. (2011). Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts. The Journal of Biological Chemistry, 286(15), 12912–12923. doi:10.1074/jbc.M110.143693.PubMedCrossRef

69.

Maeyama, M., Koga, H., Selvendiran, K., Yanagimoto, C., Hanada, S., Taniguchi, E., et al. (2008). Switching in discoid domain receptor expressions in SLUG-induced epithelial–mesenchymal transition. Cancer, 113(10), 2823–2831. doi:10.1002/cncr.23900.PubMedCrossRef

70.

Camara, J., & Jarai, G. (2010). Epithelial–mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrogenesis & Tissue Repair, 3(1), 2. doi:10.1186/1755-1536-3-2.CrossRef

71.

Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., et al. (2010). Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America, 107(35), 15449–15454. doi:10.1073/pnas.1004900107.PubMedCrossRef

72.

Sakuma, S., Saya, H., Tada, M., Nakao, M., Fujiwara, T., Roth, J. A., et al. (1996). Receptor protein tyrosine kinase DDR is up-regulated by p53 protein. FEBS Letters, 398(2–3), 165–169.PubMedCrossRef

73.

Martinez-Marignac, V. L., Rodrigue, A., Davidson, D., Couillard, M., Al-Moustafa, A. E., Abramovitz, M., et al. (2011). The effect of a DNA repair gene on cellular invasiveness: XRCC3 over-expression in breast cancer cells. PloS One, 6(1), e16394. doi:10.1371/journal.pone.0016394.PubMedCrossRef

74.

Roig, B., Moyano, S., Martorell, L., Costas, J., & Vilella, E. (2011). The Discoidin domain receptor 1 gene has a functional A2RE sequence. Journal of Neurochemistry. doi:10.1111/j.1471-4159.2011.07580.x.

75.

Shen, Q., Cicinnati, V. R., Zhang, X., Iacob, S., Weber, F., Sotiropoulos, G. C., et al. (2010). Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Molecular Cancer, 9, 227. doi:10.1186/1476-4598-9-227.PubMedCrossRef

76.

Chen, S. C., Wang, B. W., Wang, D. L., & Shyu, K. G. (2008). Hypoxia induces discoidin domain receptor-2 expression via the p38 pathway in vascular smooth muscle cells to increase their migration. Biochemical and Biophysical Research Communications, 374(4), 662–667. doi:10.1016/j.bbrc.2008.07.092.PubMedCrossRef

77.

Shyu, K. G., Wang, B. W., & Chang, H. (2009). Hyperbaric oxygen activates discoidin domain receptor 2 via tumour necrosis factor-alpha and the p38 MAPK pathway to increase vascular smooth muscle cell migration through matrix metalloproteinase 2. Clinical Science, 116(7), 575–583. doi:10.1042/CS20080215.PubMedCrossRef

78.

Chua, H. H., Yeh, T. H., Wang, Y. P., Huang, Y. T., Sheen, T. S., Lo, Y. C., et al. (2008). Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma. Head & Neck, 30(4), 427–436.CrossRef

79.

Olaso, E., Ikeda, K., Eng, F. J., Xu, L., Wang, L. H., Lin, H. C., et al. (2001). DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. The Journal of Clinical Investigation, 108(9), 1369–1378.PubMed

80.

Sekiya, Y., Ogawa, T., Yoshizato, K., Ikeda, K., & Kawada, N. (2011). Suppression of hepatic stellate cell activation by microRNA-29b. Biochemical and Biophysical Research Communications, 412(1), 74–79. doi:10.1016/j.bbrc.2011.07.041.PubMedCrossRef

81.

van Kilsdonk, J. W., van Kempen, L. C., van Muijen, G. N., Ruiter, D. J., & Swart, G. W. (2010). Soluble adhesion molecules in human cancers: Sources and fates. European Journal of Cell Biology, 89(6), 415–427. doi:10.1016/j.ejcb.2009.11.026.PubMedCrossRef

82.

Vogel, W. F. (2002). Ligand-induced shedding of discoidin domain receptor 1. FEBS Letters, 514(2–3), 175–180.PubMedCrossRef

83.

Slack, B. E., Siniaia, M. S., & Blusztajn, J. K. (2006). Collagen type I selectively activates ectodomain shedding of the discoidin domain receptor 1: Involvement of Src tyrosine kinase. Journal of Cellular Biochemistry, 98(3), 672–684.PubMedCrossRef

84.

Flynn, L. A., Blissett, A. R., Calomeni, E. P., & Agarwal, G. (2010). Inhibition of collagen fibrillogenesis by cells expressing soluble extracellular domains of DDR1 and DDR2. Journal of Molecular Biology, 395(3), 533–543. doi:10.1016/j.jmb.2009.10.073.PubMedCrossRef

85.

Lund, A. W., Stegemann, J. P., & Plopper, G. E. (2009). Mesenchymal stem cells sense three dimensional type I collagen through discoidin domain receptor 1. The Open Stem Cell Journal, 1, 40–53. doi:10.2174/1876893800901010040.PubMed

86.

Torkamani, A., Verkhivker, G., & Schork, N. J. (2009). Cancer driver mutations in protein kinase genes. Cancer Letters, 281(2), 117–127. doi:10.1016/j.canlet.2008.11.008.PubMedCrossRef

87.

Hammerman, P. S., et al. (2011). Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery, 1(1), 78–89.PubMedCrossRef

88.

Ford, C. E., Lau, S. K., Zhu, C. Q., Andersson, T., Tsao, M. S., & Vogel, W. F. (2007). Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma. British Journal of Cancer, 96(5), 808–814.PubMedCrossRef

89.

Yang, S. H., Baek, H. A., Lee, H. J., Park, H. S., Jang, K. Y., Kang, M. J., et al. (2010). Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas. Oncology Reports, 24(2), 311–319.PubMed

90.

Valencia, K., Ormazabal, C., Zandueta, C., Luis-Ravelo, D., Anton, I., Pajares, M. J., et al. (2012). Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival. Homing and colonization in lung cancer bone metastasis. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-11-1686.

91.

Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., et al. (2007). Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell, 131(6), 1190–1203. doi:10.1016/j.cell.2007.11.025.PubMedCrossRef

92.

Davies, H., Hunter, C., Smith, R., Stephens, P., Greenman, C., Bignell, G., et al. (2005). Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Research, 65(17), 7591–7595. doi:10.1158/0008-5472.CAN-05-1855.PubMed

93.

Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., et al. (2008). Somatic mutations affect key pathways in lung adenocarcinoma. Nature, 455(7216), 1069–1075. doi:10.1038/nature07423.PubMedCrossRef

94.

Vogel, W. F., Aszodi, A., Alves, F., & Pawson, T. (2001). Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Molecular and Cellular Biology, 21(8), 2906–2917.PubMedCrossRef

95.

Barker, K. T., Martindale, J. E., Mitchell, P. J., Kamalati, T., Page, M. J., Phippard, D. J., et al. (1995). Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours. Oncogene, 10(3), 569–575.PubMed

96.

Neuhaus, B., Buhren, S., Bock, B., Alves, F., Vogel, W. F., & Kiefer, F. (2011). Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors. Cellular and Molecular Life Sciences: CMLS. doi:10.1007/s00018-011-0676-8.

97.

Turashvili, G., Bouchal, J., Baumforth, K., Wei, W., Dziechciarkova, M., Ehrmann, J., et al. (2007). Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer, 7, 55. doi:10.1186/1471-2407-7-55.PubMedCrossRef

98.

Weiner, H. L., Rothman, M., Miller, D. C., & Ziff, E. B. (1996). Pediatric brain tumors express multiple receptor tyrosine kinases including novel cell adhesion kinases. Pediatric Neurosurgery, 25(2), 64–71. discussion 71-62.PubMedCrossRef

99.

Weiner, H. L., Huang, H., Zagzag, D., Boyce, H., Lichtenbaum, R., & Ziff, E. B. (2000). Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors. Neurosurgery, 47(6), 1400–1409.PubMedCrossRef

100.

Ram, R., Lorente, G., Nikolich, K., Urfer, R., Foehr, E., & Nagavarapu, U. (2006). Discoidin domain receptor-1a (DDR1a) promotes glioma cell invasion and adhesion in association with matrix metalloproteinase-2. Journal of Neuro-Oncology, 76(3), 239–248.PubMedCrossRef

101.

Yamanaka, R., Arao, T., Yajima, N., Tsuchiya, N., Homma, J., Tanaka, R., et al. (2006). Identification of expressed genes characterizing long-term survival in malignant glioma patients. Oncogene, 25(44), 5994–6002.PubMedCrossRef

102.

Yoshida, D., & Teramoto, A. (2007). Enhancement of pituitary adenoma cell invasion and adhesion is mediated by discoidin domain receptor-1. Journal of Neuro-Oncology, 82(1), 29–40.PubMedCrossRef

103.

Heinzelmann-Schwarz, V. A., Gardiner-Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Davies, M. J., et al. (2004). Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clinical Cancer Research, 10(13), 4427–4436.PubMedCrossRef

104.

Quan, J., Yahata, T., Adachi, S., Yoshihara, K., & Tanaka, K. (2011). Identification of receptor tyrosine kinase, discoidin domain receptor 1 (DDR1), as a potential biomarker for serous ovarian cancer. International Journal of Molecular Sciences, 12(2), 971–982. doi:10.3390/ijms12020971.PubMedCrossRef

105.

Colas, E., Perez, C., Cabrera, S., Pedrola, N., Monge, M., Castellvi, J., et al. (2011). Molecular markers of endometrial carcinoma detected in uterine aspirates. International Journal of Cancer. Journal International du Cancer, 129(10), 2435–2444. doi:10.1002/ijc.25901.PubMedCrossRef

106.

Nemoto, T., Ohashi, K., Akashi, T., Johnson, J. D., & Hirokawa, K. (1997). Overexpression of protein tyrosine kinases in human esophageal cancer. Pathobiology, 65(4), 195–203.PubMedCrossRef

107.

Squire, J. A., Bayani, J., Luk, C., Unwin, L., Tokunaga, J., MacMillan, C., et al. (2002). Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head & Neck, 24(9), 874–887.CrossRef

108.

Gu, T. L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., et al. (2011). Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma. PloS One, 6(1), e15640. doi:10.1371/journal.pone.0015640.PubMedCrossRef

109.

Couvelard, A., Hu, J., Steers, G., O’Toole, D., Sauvanet, A., Belghiti, J., et al. (2006). Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology, 131(5), 1597–1610.PubMedCrossRef

110.

Shimada, K., Nakamura, M., Ishida, E., Higuchi, T., Yamamoto, H., Tsujikawa, K., et al. (2008). Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer. Cancer Science, 99(1), 39–45.PubMed

111.

Rodrigues, R., Roque, L., Espadinha, C., Pinto, A., Domingues, R., Dinis, J., et al. (2007). Comparative genomic hybridization, BRAF, RAS, RET, and oligo-array analysis in aneuploid papillary thyroid carcinomas. Oncology Reports, 18(4), 917–926.PubMed

112.

Hajdu, M., Singer, S., Maki, R. G., Schwartz, G. K., Keohan, M. L., & Antonescu, C. R. (2010). IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. The Journal of Pathology, 221(3), 300–307. doi:10.1002/path.2715.PubMedCrossRef

113.

Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Wang, K. S., Mandelli, F., et al. (2005). Gene expression profiles of B-lineage adult acute lymphocytic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clinical Cancer Research, 11(20), 7209–7219. doi:10.1158/1078-0432.CCR-04-2165.PubMedCrossRef

114.

Tomasson, M. H., Xiang, Z., Walgren, R., Zhao, Y., Kasai, Y., Miner, T., et al. (2008). Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood, 111(9), 4797–4808. doi:10.1182/blood-2007-09-113027.PubMedCrossRef

115.

Loriaux, M. M., Levine, R. L., Tyner, J. W., Frohling, S., Scholl, C., Stoffregen, E. P., et al. (2008). High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia. Blood, 111(9), 4788–4796. doi:10.1182/blood-2007-07-101394.PubMedCrossRef

116.

Renne, C., Willenbrock, K., Kuppers, R., Hansmann, M. L., & Brauninger, A. (2005). Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma. Blood, 105(10), 4051–4059. doi:10.1182/blood-2004-10-4008.PubMedCrossRef

117.

Willenbrock, K., Kuppers, R., Renne, C., Brune, V., Eckerle, S., Weidmann, E., et al. (2006). Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin’s lymphoma. Haematologica, 91(5), 596–604.PubMed

118.

Labrador, J. P., Azcoitia, V., Tuckermann, J., Lin, C., Olaso, E., Manes, S., et al. (2001). The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Reports, 2(5), 446–452.PubMed

119.

Bargal, R., Cormier-Daire, V., Ben-Neriah, Z., Le Merrer, M., Sosna, J., Melki, J., et al. (2009). Mutations in DDR2 gene cause SMED with short limbs and abnormal calcifications. American Journal of Human Genetics, 84(1), 80–84. doi:10.1016/j.ajhg.2008.12.004.PubMedCrossRef

120.

Ali, B. R., Xu, H., Akawi, N. A., John, A., Karuvantevida, N. S., Langer, R., et al. (2010). Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients. Human Molecular Genetics, 19(11), 2239–2250. doi:10.1093/hmg/ddq103.PubMedCrossRef

121.

Kano, K., Marin de Evsikova, C., Young, J., Wnek, C., Maddatu, T. P., Nishina, P. M., et al. (2008). A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse. Molecular Endocrinology, 22(8), 1866–1880. doi:10.1210/me.2007-0310.PubMedCrossRef

122.

Matsumura, H., Kano, K., Marin de Evsikova, C., Young, J. A., Nishina, P. M., Naggert, J. K., et al. (2009). Transcriptome analysis reveals an unexpected role of a collagen tyrosine kinase receptor gene, Ddr2, as a regulator of ovarian function. Physiological Genomics, 39(2), 120–129. doi:10.1152/physiolgenomics.00073.2009.PubMedCrossRef

123.

Kano, K., Kitamura, A., Matsuwaki, T., Morimatsu, M., & Naito, K. (2010). Discoidin domain receptor 2 (DDR2) is required for maintenance of spermatogenesis in male mice. Molecular Reproduction and Development, 77(1), 29–37. doi:10.1002/mrd.21093.PubMedCrossRef

124.

Faraci-Orf, E., McFadden, C., & Vogel, W. F. (2006). DDR1 signaling is essential to sustain Stat5 function during lactogenesis. Journal of Cellular Biochemistry, 97(1), 109–121. doi:10.1002/jcb.20618.PubMedCrossRef

125.

Gross, O., Beirowski, B., Harvey, S. J., McFadden, C., Chen, D., Tam, S., et al. (2004). DDR1-deficient mice show localized subepithelial GBM thickening with focal loss of slit diaphragms and proteinuria. Kidney International, 66(1), 102–111.PubMedCrossRef

126.

Curat, C. A., & Vogel, W. F. (2002). Discoidin domain receptor 1 controls growth and adhesion of mesangial cells. Journal of the American Society of Nephrology, 13(11), 2648–2656.PubMedCrossRef

127.

Meyer zum Gottesberge, A. M., Gross, O., Becker-Lendzian, U., Massing, T., & Vogel, W. F. (2008). Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1. Laboratory Investigation, 88(1), 27–37.PubMedCrossRef

128.

Olaso, E., Labrador, J. P., Wang, L., Ikeda, K., Eng, F. J., Klein, R., et al. (2002). Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2. The Journal of Biological Chemistry, 277(5), 3606–3613.PubMedCrossRef

129.

Olaso, E., Arteta, B., Benedicto, A., Crende, O., & Friedman, S. L. (2011). Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages. The American Journal of Pathology, 179(6), 2894–2904. doi:10.1016/j.ajpath.2011.09.002.PubMedCrossRef

130.

Badiola, I., Olaso, E., Crende, O., Friedman, S. L., & Vidal-Vanaclocha, F. (2011). Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut. doi:10.1136/gutjnl-2011-300810.

131.

Roberts, M. E., Magowan, L., Hall, I. P., & Johnson, S. R. (2011). Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production. The European Respiratory Journal, 37(6), 1482–1493. doi:10.1183/09031936.00039710.PubMedCrossRef

132.

Dang, N., Hu, J., Liu, X., Li, X., Ji, S., Zhang, W., et al. (2009). CD167 acts as a novel costimulatory receptor in T-cell activation. Journal of Immunotherapy, 32(8), 773–784. doi:10.1097/CJI.0b013e3181acea46.PubMedCrossRef

133.

Shyu, K. G., Wang, B. W., Kuan, P., & Chang, H. (2008). RNA interference for discoidin domain receptor 2 attenuates neointimal formation in balloon injured rat carotid artery. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(8), 1447–1453. doi:10.1161/ATVBAHA.108.165993.PubMedCrossRef

134.

Badiola, I., Villace, P., Basaldua, I., & Olaso, E. (2011). Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. Oncology Reports, 26(4), 971–978. doi:10.3892/or.2011.1356.PubMed

135.

Franco, C., Ahmad, P. J., Hou, G., Wong, E., & Bendeck, M. P. (2010). Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circulation Research, 106(11), 1775–1783. doi:10.1161/CIRCRESAHA.109.213637.PubMedCrossRef

136.

Wall, S. J., Werner, E., Werb, Z., & DeClerck, Y. A. (2005). Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. The Journal of Biological Chemistry, 280(48), 40187–40194.PubMedCrossRef

137.

Bhatt, R. S., Tomoda, T., Fang, Y., & Hatten, M. E. (2000). Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. Genes & Development, 14(17), 2216–2228.CrossRef

138.

Suzuki, N., Ando, S., Sumida, K., Horie, N., & Saito, K. (2011). Analysis of altered gene expression specific to embryotoxic chemical treatment during embryonic stem cell differentiation into myocardiac and neural cells. The Journal of Toxicological Sciences, 36(5), 569–585.PubMedCrossRef

139.

Franco-Pons, N., Tomas, J., Roig, B., Auladell, C., Martorell, L., & Vilella, E. (2009). Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro. Journal of Molecular Neuroscience: MN, 38(1), 2–11. doi:10.1007/s12031-008-9151-x.PubMedCrossRef

140.

Zurakowski, H., Gagnon, A., Landry, A., Layne, M. D., & Sorisky, A. (2007). Discoidin domain receptor 2 impairs insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation and glucose uptake in 3T3-L1 adipocytes. Hormone and Metabolic Research, 39(8), 575–581.PubMedCrossRef

141.

Thiery, J. P., Acloque, H., Huang, R. Y., & Nieto, M. A. (2009). Epithelial–mesenchymal transitions in development and disease. Cell, 139(5), 871–890. doi:10.1016/j.cell.2009.11.007.PubMedCrossRef

142.

Goldsmith, E. C., Zhang, X., Watson, J., Hastings, J., & Potts, J. D. (2010). The collagen receptor DDR2 is expressed during early cardiac development. Anatomical Record, 293(5), 762–769. doi:10.1002/ar.20922.CrossRef

143.

Zhou, B., von Gise, A., Ma, Q., Hu, Y. W., & Pu, W. T. (2010). Genetic fate mapping demonstrates contribution of epicardium-derived cells to the annulus fibrosis of the mammalian heart. Developmental Biology, 338(2), 251–261. doi:10.1016/j.ydbio.2009.12.007.PubMedCrossRef

144.

Walsh, L. A., Nawshad, A., & Medici, D. (2011). Discoidin domain receptor 2 is a critical regulator of epithelial–mesenchymal transition. Matrix Biology, 30(4), 243–247. doi:10.1016/j.matbio.2011.03.007.PubMedCrossRef

145.

Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M., et al. (2005). DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene, 24(14), 2375–2385. doi:10.1038/sj.onc.1208429.PubMedCrossRef

146.

Blick, T., Hugo, H., Widodo, E., Waltham, M., Pinto, C., Mani, S. A., et al. (2010). Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/−) stem cell phenotype in human breast cancer. Journal of Mammary Gland Biology and Neoplasia, 15(2), 235–252. doi:10.1007/s10911-010-9175-z.PubMedCrossRef

147.

Hou, G., Vogel, W. F., & Bendeck, M. P. (2002). Tyrosine kinase activity of discoidin domain receptor 1 is necessary for smooth muscle cell migration and matrix metalloproteinase expression. Circulation Research, 90(11), 1147–1149.PubMedCrossRef

148.

Kamohara, H., Yamashiro, S., Galligan, C., & Yoshimura, T. (2001). Discoidin domain receptor 1 isoform-a (DDR1alpha) promotes migration of leukocytes in three-dimensional collagen lattices. The FASEB Journal, 15(14), 2724–2726.

149.

Fukunaga-Kalabis, M., Martinez, G., Liu, Z. J., Kalabis, J., Mrass, P., Weninger, W., et al. (2006). CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1. The Journal of Cell Biology, 175(4), 563–569.PubMedCrossRef

150.

Franco, C., Britto, K., Wong, E., Hou, G., Zhu, S. N., Chen, M., et al. (2009). Discoidin domain receptor 1 on bone marrow-derived cells promotes macrophage accumulation during atherogenesis. Circulation Research, 105(11), 1141–1148. doi:10.1161/CIRCRESAHA.109.207357.PubMedCrossRef

151.

Song, S., Shackel, N. A., Wang, X. M., Ajami, K., McCaughan, G. W., & Gorrell, M. D. (2011). Discoidin domain receptor 1: Isoform expression and potential functions in cirrhotic human liver. The American Journal of Pathology, 178(3), 1134–1144. doi:10.1016/j.ajpath.2010.11.068.PubMedCrossRef

152.

Hou, G., Wang, D., & Bendeck, M. P. (2011). Deletion of discoidin domain receptor 2 does not affect smooth muscle cell adhesion, migration, or proliferation in response to type I collagen. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology. doi:10.1016/j.carpath.2011.07.006.

153.

Bhadriraju, K., Chung, K. H., Spurlin, T. A., Haynes, R. J., Elliott, J. T., & Plant, A. L. (2009). The relative roles of collagen adhesive receptor DDR2 activation and matrix stiffness on the downregulation of focal adhesion kinase in vascular smooth muscle cells. Biomaterials, 30(35), 6687–6694. doi:10.1016/j.biomaterials.2009.08.036.PubMedCrossRef

154.

Zamir, E., & Geiger, B. (2001). Components of cell–matrix adhesions. Journal of Cell Science, 114(Pt 20), 3577–3579.PubMed

155.

Etienne, J., & Duperray, A. (2011). Initial dynamics of cell spreading are governed by dissipation in the actin cortex. Biophysical Journal, 101(3), 611–621. doi:10.1016/j.bpj.2011.06.030.PubMedCrossRef

156.

Hachehouche, L. N., Chetoui, N., & Aoudjit, F. (2010). Implication of discoidin domain receptor 1 in T cell migration in three-dimensional collagen. Molecular Immunology, 47(9), 1866–1869. doi:10.1016/j.molimm.2010.02.023.PubMedCrossRef

157.

Guerrot, D., Kerroch, M., Placier, S., Vandermeersch, S., Trivin, C., Mael-Ainin, M., et al. (2011). Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy. The American Journal of Pathology, 179(1), 83–91. doi:10.1016/j.ajpath.2011.03.023.PubMedCrossRef

158.

Park, H. S., Kim, K. R., Lee, H. J., Choi, H. N., Kim, D. K., Kim, B. T., et al. (2007). Overexpression of discoidin domain receptor 1 increases the migration and invasion of hepatocellular carcinoma cells in association with matrix metalloproteinase. Oncology Reports, 18(6), 1435–1441.PubMed

159.

Castro-Sanchez, L., Soto-Guzman, A., Navarro-Tito, N., Martinez-Orozco, R., & Salazar, E. P. (2010). Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells. European Journal of Cell Biology, 89(11), 843–852. doi:10.1016/j.ejcb.2010.07.004.PubMedCrossRef

160.

Rowe, R. G., & Weiss, S. J. (2009). Navigating ECM barriers at the invasive front: The cancer cell–stroma interface. Annual Review of Cell and Developmental Biology, 25, 567–595. doi:10.1146/annurev.cellbio.24.110707.175315.PubMedCrossRef

161.

Castro-Sanchez, L., Soto-Guzman, A., Guaderrama-Diaz, M., Cortes-Reynosa, P., & Salazar, E. P. (2011). Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells. Clinical & Experimental Metastasis, 28(5), 463–477. doi:10.1007/s10585-011-9385-9.CrossRef

162.

Gschwind, A., Fischer, O. M., & Ullrich, A. (2004). The discovery of receptor tyrosine kinases: Targets for cancer therapy. Nature Reviews. Cancer, 4(5), 361–370. doi:10.1038/nrc1360.PubMedCrossRef

163.

Zhang, J., Yang, P. L., & Gray, N. S. (2009). Targeting cancer with small molecule kinase inhibitors. Nature Reviews. Cancer, 9(1), 28–39. doi:10.1038/nrc2559.PubMedCrossRef

164.

Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., et al. (2007). Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. Blood, 110(12), 4055–4063. doi:10.1182/blood-2007-07-102061.PubMedCrossRef

165.

Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., et al. (2007). Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nature Biotechnology, 25(9), 1035–1044. doi:10.1038/nbt1328.PubMedCrossRef

166.

Hantschel, O., Rix, U., & Superti-Furga, G. (2008). Target spectrum of the BCR-ABL inhibitors imatinib, nilotinib and dasatinib. Leukemia & Lymphoma, 49(4), 615–619. doi:10.1080/10428190801896103.CrossRef

167.

Day, E., Waters, B., Spiegel, K., Alnadaf, T., Manley, P. W., Buchdunger, E., et al. (2008). Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. European Journal of Pharmacology, 599(1–3), 44–53. doi:10.1016/j.ejphar.2008.10.014.PubMedCrossRef

168.

Li, J., Rix, U., Fang, B., Bai, Y., Edwards, A., Colinge, J., et al. (2010). A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nature Chemical Biology, 6(4), 291–299. doi:10.1038/nchembio.332.PubMedCrossRef

169.

Rix, U., Remsing Rix, L. L., Terker, A. S., Fernbach, N. V., Hantschel, O., Planyavsky, M., et al. (2010). A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. Leukemia, U.K, 24(1), 44–50. doi:10.1038/leu.2009.228.CrossRef

170.

Sun, X., Phan, T. N., Jung, S. H., Kim, S. Y., Cho, J. U., Lee, H., et al. (2011). LCB 03-0110, a novel pan-DDR/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation. The Journal of Pharmacology and Experimental Therapeutics. doi:10.1124/jpet.111.187328.

171.

Yang, X., Huang, Y., Crowson, M., Li, J., Maitland, M. L., & Lussier, Y. A. (2010). Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data. Journal of Biomedical Informatics, 43(3), 376–384. doi:10.1016/j.jbi.2010.04.006.PubMedCrossRef

172.

Du, J., Bernasconi, P., Clauser, K. R., Mani, D. R., Finn, S. P., Beroukhim, R., et al. (2009). Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy. Nature Biotechnology, 27(1), 77–83. doi:10.1038/nbt.1513.PubMedCrossRef

173.

Mihai, C., Iscru, D. F., Druhan, L. J., Elton, T. S., & Agarwal, G. (2006). Discoidin domain receptor 2 inhibits fibrillogenesis of collagen type 1. Journal of Molecular Biology, 361(5), 864–876.PubMedCrossRef

174.

Siddiqui, K., Kim, G. W., Lee, D. H., Shin, H. R., Yang, E. G., Lee, N. T., et al. (2009). Actinomycin D identified as an inhibitor of discoidin domain receptor 2 interaction with collagen through an insect cell based screening of a drug compound library. Biological & Pharmaceutical Bulletin, 32(1), 136–141.CrossRef

175.

Turashvili, G., Bouchal, J., Ehrmann, J., Fridman, E., Skarda, J., & Kolar, Z. (2007). Novel immunohistochemical markers for the differentiation of lobular and ductal invasive breast carcinomas. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 151(1), 59–64.PubMed

176.

Tun, H. W., Personett, D., Baskerville, K. A., Menke, D. M., Jaeckle, K. A., Kreinest, P., et al. (2008). Pathway analysis of primary central nervous system lymphoma. Blood, 111(6), 3200–3210. doi:10.1182/blood-2007-10-119099.PubMedCrossRef

177.

Ahmad, P. J., Trcka, D., Xue, S., Franco, C., Speer, M. Y., Giachelli, C. M., et al. (2009). Discoidin domain receptor-1 deficiency attenuates atherosclerotic calcification and smooth muscle cell-mediated mineralization. The American Journal of Pathology, 175(6), 2686–2696. doi:10.2353/ajpath.2009.080734.PubMedCrossRef

178.

Flamant, M., Placier, S., Rodenas, A., Curat, C. A., Vogel, W. F., Chatziantoniou, C., et al. (2006). Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. Journal of the American Society of Nephrology, 17(12), 3374–3381.PubMedCrossRef

179.

Avivi-Green, C., Singal, M., & Vogel, W. F. (2006). Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. American Journal of Respiratory and Critical Care Medicine, 174(4), 420–427.PubMedCrossRef

180.

Franco, C., Hou, G., Ahmad, P. J., Fu, E. Y., Koh, L., Vogel, W. F., et al. (2008). Discoidin domain receptor 1 (ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circulation Research, 102(10), 1202–1211. doi:10.1161/CIRCRESAHA.107.170662.PubMedCrossRef

181.

Gross, O., Girgert, R., Beirowski, B., Kretzler, M., Kang, H. G., Kruegel, J., et al. (2010). Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease. Matrix Biology, 29(5), 346–356. doi:10.1016/j.matbio.2010.03.002.PubMedCrossRef

182.

Ferri, N., Carragher, N. O., & Raines, E. W. (2004). Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: Potential implications in atherosclerosis and lymphangioleiomyomatosis. American Journal of Pathology, 164(5), 1575–1585.PubMedCrossRef

183.

Blissett, A. R., Garbellini, D., Calomeni, E. P., Mihai, C., Elton, T. S., & Agarwal, G. (2009). Regulation of collagen fibrillogenesis by cell-surface expression of kinase dead DDR2. Journal of Molecular Biology, 385(3), 902–911. doi:10.1016/j.jmb.2008.10.060.PubMedCrossRef

184.

Xu, L., Peng, H., Wu, D., Hu, K., Goldring, M. B., Olsen, B. R., et al. (2005). Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. The Journal of Biological Chemistry, 280(1), 548–555.PubMedCrossRef

185.

Xu, L., Peng, H., Glasson, S., Lee, P. L., Hu, K., Ijiri, K., et al. (2007). Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis and Rheumatism, 56(8), 2663–2673.PubMedCrossRef

186.

Wang, J., Lu, H., Liu, X., Deng, Y., Sun, T., Li, F., et al. (2002). Functional analysis of discoidin domain receptor 2 in synovial fibroblasts in rheumatoid arthritis. Journal of Autoimmunity, 19(3), 161–168.PubMedCrossRef

187.

Su, J., Yu, J., Ren, T., Zhang, W., Zhang, Y., Liu, X., et al. (2009). Discoidin domain receptor 2 is associated with the increased expression of matrix metalloproteinase-13 in synovial fibroblasts of rheumatoid arthritis. Molecular and Cellular Biochemistry, 330(1–2), 141–152. doi:10.1007/s11010-009-0127-0.PubMedCrossRef

Title: Discoidin domain receptor tyrosine kinases: new players in cancer progression
Authors: Rajeshwari R. Valiathan
Marta Marco
Birgit Leitinger
Celina G. Kleer
Rafael Fridman
Publication date: 01-06-2012
Publisher: Springer US
Published in: Cancer and Metastasis Reviews / Issue 1-2/2012
Print ISSN: 0167-7659
Electronic ISSN: 1573-7233
DOI: https://doi.org/10.1007/s10555-012-9346-z

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1-2/2012

Role of the ubiquitin ligase Fbw7 in cancer progression

Bee venom in cancer therapy

Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities

The present and future of gene profiling in breast cancer

Cooperate concept of metastasis: site-specific requirement of activated differentiation and dynamic deterioration

Starvation tactics for solid tumors: tumor blood flow interruption via a combretastatin derivative (Cderiv), and its microcirculation mechanism

Keynote webinar | Spotlight on antibody–drug conjugates in cancer